Milind D Kachare1, Swapnil D Kachare2, Bradley J Vivace3, Omar Elfanagely4, Brooke Barrow5, Adam O'Toole1, Alyssa M Simpson1, Rachel Safeek5, Joshua H Choo1, Terry M McCurry1, Bradon J Wilhelmi1. 1. Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Louisville, Louisville, KY. 2. Division of Plastic and Reconstructive Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 3. Department of Orthopaedic Surgery, University of Missouri, Columbia, MO. 4. Division of General Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ. 5. University of Louisville School of Medicine, Louisville, KY.
Abstract
Background: Breast reconstruction in the obese patient is often fraught with poor patient satisfaction due to inadequate volume restoration. The off-label hyperinflation of saline implants is a direct yet controversial solution to this problem, with limited studies in the literature. This study sought to determine the safety and efficacy of this technique for breast reconstruction. Methods: A retrospective chart review was performed to identify all patients with a body mass index (BMI) greater than or equal to 30 kg/m2 who underwent breast reconstruction between the years 2013 to 2020 with saline implants filled beyond the manufacturer's maximum recommended volume. Results: The 21 patients identified had an average age of 49 years. The mean BMI was 39.5 kg/m2. A total of 42 implants were placed; 34 were 800 mL, 4 were 750 mL, and 4 were 700 mL. The average overfill volume was 302 mL (138%). Mean follow-up was 65.0 months. Of these, 1 (4.8%) patient with a history of chest wall radiotherapy underwent reoperation for unilateral implant exposure 27 days after the index procedure, no patient sustained spontaneous leak or rupture, and 1 patient had unilateral deflation following emergent central line and pacemaker placement 2 years after the implant was placed for an unrelated cardiovascular event. Conclusions: Hyperinflation of saline implants beyond the maximum recommended volume may be considered for volume replacement in obese patients undergoing implant-based breast reconstruction. This practice is well tolerated, has a complication rate comparable to using implants filled to the recommended volume, and has the potential to restore lost breast volume in the obese patient post mastectomy.
Background: Breast reconstruction in the obese patient is often fraught with poor patient satisfaction due to inadequate volume restoration. The off-label hyperinflation of saline implants is a direct yet controversial solution to this problem, with limited studies in the literature. This study sought to determine the safety and efficacy of this technique for breast reconstruction. Methods: A retrospective chart review was performed to identify all patients with a body mass index (BMI) greater than or equal to 30 kg/m2 who underwent breast reconstruction between the years 2013 to 2020 with saline implants filled beyond the manufacturer's maximum recommended volume. Results: The 21 patients identified had an average age of 49 years. The mean BMI was 39.5 kg/m2. A total of 42 implants were placed; 34 were 800 mL, 4 were 750 mL, and 4 were 700 mL. The average overfill volume was 302 mL (138%). Mean follow-up was 65.0 months. Of these, 1 (4.8%) patient with a history of chest wall radiotherapy underwent reoperation for unilateral implant exposure 27 days after the index procedure, no patient sustained spontaneous leak or rupture, and 1 patient had unilateral deflation following emergent central line and pacemaker placement 2 years after the implant was placed for an unrelated cardiovascular event. Conclusions: Hyperinflation of saline implants beyond the maximum recommended volume may be considered for volume replacement in obese patients undergoing implant-based breast reconstruction. This practice is well tolerated, has a complication rate comparable to using implants filled to the recommended volume, and has the potential to restore lost breast volume in the obese patient post mastectomy.
Authors: Patrick B Garvey; Mark T Villa; Alexander T Rozanski; Jun Liu; Geoffrey L Robb; Elisabeth K Beahm Journal: Plast Reconstr Surg Date: 2012-11 Impact factor: 4.730
Authors: Dhivya R Srinivasa; Mark W Clemens; Ji Qi; Jennifer B Hamill; Hyungjin M Kim; Andrea L Pusic; Edwin G Wilkins; Charles E Butler; Patrick B Garvey Journal: Plast Reconstr Surg Date: 2020-03 Impact factor: 4.730
Authors: John P Fischer; Jonas A Nelson; Stephen J Kovach; Joseph M Serletti; Liza C Wu; Suhail Kanchwala Journal: J Am Coll Surg Date: 2013-07-25 Impact factor: 6.113
Authors: E K M Tjeertes; Elke E K M Tjeertes; S E Hoeks; Sanne S E Hoeks; S B J Beks; Sabine S B J C Beks; T M Valentijn; Tabita T M Valentijn; A G M Hoofwijk; Anton A G M Hoofwijk; R J Stolker; Robert Jan R J Stolker Journal: BMC Anesthesiol Date: 2015-07-31 Impact factor: 2.217